TAVR | tctmd.com

News Daily News

UK TAVI Registry Supports Use of Subclavian Access When Transfemoral Not Possible

By L.A. McKeown

September 16, 2015

News Industry News

A Significant Achievement for Allium Medical: Gardia's WIRION® Embolic Protection Device Received FDA Clearance for the Carotid Indication

June 08, 2015

News Industry News

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

June 03, 2015

News Industry News

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

July 27, 2015

News Daily News

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

By Todd Neale

September 17, 2015

News Industry News

St. Jude Medical Gains CE Mark for 27mm & 29mm Portico TAVR Valves to Complete a Full Portfolio of Portico Sizing Options for Physicians Treating Patients with Aortic Stenosis

September 18, 2015

News Daily News

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

By Todd Neale

July 27, 2015

News Daily News

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

July 07, 2015

News Daily News

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

September 09, 2015

News Industry News

TAVR program raises margin 350% by befriending rivals

June 15, 2015

Subscribe to TAVR

Advertisement

UK TAVI Registry Supports Use of Subclavian Access When Transfemoral Not Possible

A Significant Achievement for Allium Medical: Gardia's WIRION® Embolic Protection Device Received FDA Clearance for the Carotid Indication

St. Jude Medical Receives FDA Approval to Resume U.S. Evaluation of the Portico System

Essential Medical Inc. Announces Successful Commencement of EU Studies for MANTA™ Large Bore Vascular Closure Device

Mechanical Circulatory Support in TAVR Tied to Worse Outcomes, Higher Costs

St. Jude Medical Gains CE Mark for 27mm & 29mm Portico TAVR Valves to Complete a Full Portfolio of Portico Sizing Options for Physicians Treating Patients with Aortic Stenosis

Study Suggests Patient Age of 90 Years or More Should Not Preclude TAVR

Survival Benefit of CoreValve in High-Risk Patients Persists at 2 Years

ProGlide Tops Prostar XL for Access-Site Closure After Transfemoral TAVR

TAVR program raises margin 350% by befriending rivals

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content